BACKGROUND: Carotid endarterectomy (CEA) and carotid artery stenting (CAS) can be used to prevent stroke due to arteriosclerotic lesions of the carotid artery. In Germany, legally mandated quality assurance (QA) enables the evaluation of outcome quality after CEA and CAS performed under routine conditions. METHODS: We analyzed data on all elective CEA and CAS procedures performed over the periods 2009-2014 and 2012-2014, respectively. The endpoints of the study were the combined in-hospital stroke and death rate, stroke rate and mortality separately, local complications, and other complications. We analyzed the raw data with descriptive statistics and carried out a risk-adjusted analysis of the association of clinically unalterable variables with the risk of stroke and death. All analyses were performed separately for CEA and CAS. RESULTS: Data were analyzed from 142 074 CEA procedures (67.8% of them in men) and 13 086 CAS procedures (69.7% in men). The median age was 72 years (CEA) and 71 years (CAS). The periprocedural rate of stroke and death after CEA was 1.4% for asymptomatic and 2.5% for symptomatic stenoses; the corresponding rates for CAS were 1.7% and 3.7%. Variables associated with increased risk included older age, higher ASA class (ASA = American Society of Anesthesiologists), symptomatic vs. asymptomatic stenosis, 50-69% stenosis, and contralateral carotid occlusion (for CEA only). CONCLUSION: These data reveal a low periprocedural rate of stroke or death for both CEA and CAS. This study does however not permit any conclusions as to the superiority or inferiority of CEA and CAS.
BACKGROUND: Carotid endarterectomy (CEA) and carotid artery stenting (CAS) can be used to prevent stroke due to arteriosclerotic lesions of the carotid artery. In Germany, legally mandated quality assurance (QA) enables the evaluation of outcome quality after CEA and CAS performed under routine conditions. METHODS: We analyzed data on all elective CEA and CAS procedures performed over the periods 2009-2014 and 2012-2014, respectively. The endpoints of the study were the combined in-hospital stroke and death rate, stroke rate and mortality separately, local complications, and other complications. We analyzed the raw data with descriptive statistics and carried out a risk-adjusted analysis of the association of clinically unalterable variables with the risk of stroke and death. All analyses were performed separately for CEA and CAS. RESULTS: Data were analyzed from 142 074 CEA procedures (67.8% of them in men) and 13 086 CAS procedures (69.7% in men). The median age was 72 years (CEA) and 71 years (CAS). The periprocedural rate of stroke and death after CEA was 1.4% for asymptomatic and 2.5% for symptomatic stenoses; the corresponding rates for CAS were 1.7% and 3.7%. Variables associated with increased risk included older age, higher ASA class (ASA = American Society of Anesthesiologists), symptomatic vs. asymptomatic stenosis, 50-69% stenosis, and contralateral carotid occlusion (for CEA only). CONCLUSION: These data reveal a low periprocedural rate of stroke or death for both CEA and CAS. This study does however not permit any conclusions as to the superiority or inferiority of CEA and CAS.
Authors: Mohammad H Eslami; James T McPhee; Jessica P Simons; Andres Schanzer; Louis M Messina Journal: J Vasc Surg Date: 2010-11-18 Impact factor: 4.268
Authors: Michal Tendera; Victor Aboyans; Marie-Louise Bartelink; Iris Baumgartner; Denis Clément; Jean-Philippe Collet; Alberto Cremonesi; Marco De Carlo; Raimund Erbel; F Gerry R Fowkes; Magda Heras; Serge Kownator; Erich Minar; Jan Ostergren; Don Poldermans; Vincent Riambau; Marco Roffi; Joachim Röther; Horst Sievert; Marc van Sambeek; Thomas Zeller Journal: Eur Heart J Date: 2011-08-26 Impact factor: 29.983
Authors: P Tsantilas; A Kühnl; M Kallmayer; C Knappich; S Schmid; A Kuetchou; A Zimmermann; H H Eckstein Journal: J Cardiovasc Surg (Torino) Date: 2015-09-24 Impact factor: 1.888
Authors: M Fokkema; G J de Borst; B W Nolan; J Indes; D B Buck; R C Lo; F L Moll; M L Schermerhorn Journal: Eur J Vasc Endovasc Surg Date: 2013-10-01 Impact factor: 7.069
Authors: Barbara Rantner; Barbara Kollerits; Gary S Roubin; Peter A Ringleb; Olaf Jansen; George Howard; Jeroen Hendrikse; Alison Halliday; John Gregson; Hans-Henning Eckstein; David Calvet; Richard Bulbulia; Leo H Bonati; Jean-Pierre Becquemin; Ale Algra; Martin M Brown; Jean-Louis Mas; Thomas G Brott; Gustav Fraedrich Journal: Stroke Date: 2017-04-28 Impact factor: 7.914
Authors: Sofie Schmid; Pavlos Tsantilas; Christoph Knappich; Michael Kallmayer; Thomas König; Thorben Breitkreuz; Alexander Zimmermann; Andreas Kuehnl; Hans-Henning Eckstein Journal: J Am Heart Assoc Date: 2017-03-13 Impact factor: 5.501